Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Increases Clostridia - : clostridium butyricum (probiotics),Miya,Miyarisan |
📓
Supplemental <i>Clostridium butyricum</i> Modulates Lipid Metabolism Through Shaping Gut Microbiota and Bile Acid Profile of Aged Laying Hens. Frontiers in microbiology (Front Microbiol ) Vol: 11 Issue Pages: 600 Pub: 2020 Epub: 2020 Apr 15 Authors Wang WW , Wang J , Zhang HJ , Wu SG , Qi GH , Html Article Publication |
| Increases Clostridia - : clostridium butyricum (probiotics),Miya,Miyarisan |
📓
<i>Clostridium butyricum</i> CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells. Frontiers in immunology (Front Immunol ) Vol: 8 Issue Pages: 1345 Pub: 2017 Epub: 2017 Oct 19 Authors Jia L , Shan K , Pan LL , Feng N , Lv Z , Sun Y , Li J , Wu C , Zhang H , Chen W , Diana J , Sun J , Chen YQ , Html Article Publication |
| Decreases Clostridia - : clostridium butyricum (probiotics),Miya,Miyarisan |
👪
Dietary Clostridium butyricum Induces a Phased Shift in Fecal Microbiota Structure and Increases the Acetic Acid-Producing Bacteria in a Weaned Piglet Model. Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 66 Issue 20 Pages: 5157-5166 Pub: 2018 May 23 Epub: 2018 Apr 30 Authors Zhang J , Chen X , Liu P , Zhao J , Sun J , Guan W , Johnston LJ , Levesque CL , Fan P , He T , Zhang G , Ma X , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.